Literature DB >> 156337

Studies of the combination of adriamycin and cyclophosphamide (alone or with other agents) for the treatment of breast cancer.

S E Salmon, S E Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 156337     DOI: 10.1159/000225316

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


× No keyword cloud information.
  4 in total

1.  Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer.

Authors:  C Manegold; P Worst; J Bickel; H Schmid; P Drings; M Kaufmann
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Adjuvant chemotherapy in breast cancer: To use or not to use, the anthracyclines.

Authors:  Jennifer A Crozier; Abhisek Swaika; Alvaro Moreno-Aspitia
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  Ifosfamide combination chemotherapy in advanced breast cancer.

Authors:  H Schmid; M Kaufmann; E M Grischke; G Bastert
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathy.

Authors:  R Lenzhofer; R Dudczak; G Gumhold; W Graninger; K Moser; K H Spitzy
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.